Loading data
JSPRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 41.64 m USD | 34.27 m USD | — | — | — |
| Research and development expense | 63.1 m USD | 55.82 m USD | 51.79 m USD | 34.63 m USD | 25.42 m USD |
| Operating profit | -83.88 m USD | -76.24 m USD | -68.86 m USD | -51.2 m USD | -36.83 m USD |
| Income tax expense | — | 2 k USD | 2 k USD | — | — |
| Net income (reported basis) | -75.8 USD | -71.3 m USD | -64.5 m USD | -37.7 m USD | -30.64 m USD |
| Net income attributable to common shareholders | — | -71.27 m USD | -64.47 m USD | — | — |
| Basic earnings per share | -3.95 USD/share | -4.89 USD/share | -6.18 USD/share | -10.33 USD/share | -2.69 USD/share |
| Diluted earnings per share | -3.95 USD/share | -4.89 USD/share | -6.18 USD/share | -10.33 USD/share | -2.69 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.